Gentex earned $0.43 per diluted share in the third quarter of 2026, below Wall Street expectations near $0.50, and GNTX shares reached opened at a reported 52-week low of $20.21. Levi & Korsinsky is investigating on behalf of shareholders who lost money.
NEW YORK, Oct. 28, 2026 /PRNewswire/ -- At $0.43 per diluted share, Gentex Corporation's (NASDAQ: GNTX) third-quarter 2026 earnings, released October 23, 2026, came in roughly 14% below the approximately $0.50 Wall Street expected, and GNTX shares faltered. If you bought GNTX at a higher price, you may have suffered a loss and may have legal rights. Shareholders who lost money on Gentex are encouraged to request a review of their GNTX losses now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
On an adjusted basis, Gentex reported $0.47 per share, which was still below the consensus figure. Quarterly sales came in at $647.7 million. That was roughly $22 million short of the approximately $670 million analysts projected and below the $655.2 million Gentex reported for the third quarter of 2025.
Gentex cited certain customer issues and delayed launches during the quarter. Levi & Korsinsky is investigating whether Gentex shareholders who suffered losses may be able to recover them.
Purchased Gentex shares and now facing a loss? Find out if you may qualify to recover , or reach Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
Levi & Korsinsky, LLP -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.
Frequently Asked Questions About the GNTX Investigation
Q: How much did GNTX stock drop? A: GNTX shares fell to open at a reported 52-week low of $20.21 after the Company released third-quarter 2026 results showing sales of $647.7 million and gross margin of 33.4%. Investors who purchased shares and suffered losses may be eligible to participate in the investigation.
Q: Who is eligible to participate in the GNTX investigation? A: Investors who purchased GNTX stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do GNTX investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my GNTX shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought GNTX and sold at a loss may still participate in the investigation.
Q: What if my GNTX losses are small -- is it still worth contacting a lawyer? A: Yes. There is no minimum loss amount required to participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/levi--korsinsky-notifies-investors-of-pending-investigation-into-securities-claims-involving-gentex-corporation-gntx-302921868.html
SOURCE Levi & Korsinsky, LLP
